Download presentation
Published byIsaac Boone Modified over 9 years ago
1
Use of Modelling for PKPD Studies in Infectious Diseases
Joe Standing Infectious Diseases and Microbiology Unit UCL Institute of Child Health, London ESPID May 2012
2
Outline Principles of PKPD in microbiology and infectious diseases
Introduction to nonlinear mixed effects modelling Scaling pharmacokinetics between adults and children
3
Mathematical model mathematical model n. a description or representation of something conceived or presented in mathematical terms. (OED) Population modelling with nonlinear mixed effects is recommended
4
Principles of antimicrobial PKPD
5
Principles of antimicrobial PKPD
6
In vitro PKPD
8
Principles of antimicrobial PKPD
9
Clinical data: Cmax/MIC
RATE OF CLINICAL RESPONSE VS. CMAX/MIC RATIO
10
Clinical data: AUC/MIC
11
Clinical data: AUC/MIC
12
Clinical data T>MIC
Clinical evidence lacking…
13
Clinical data T>MIC
…although some promising findings in critically ill patients with Pseudomonas:
14
Infusion length: T>MIC
Figure 3 Optimal infusion time plotted against MIC for meropenem. Green shaded area represents Eucast E.coli breakpoints of 2 and 8mg/L Standing et al 2011 PAGE
15
Be careful …
16
Antiviral PKPD Standing et al 2012 AAC in press
17
Antiviral PKPD
18
HIV viral load/CD4
19
HIV viral load/CD4
20
Outline Principles of PKPD in microbiology and infectious diseases
Introduction to nonlinear mixed effects modelling Scaling pharmacokinetics between adults and children
21
Variability
22
Possible modelling approaches
Naïve Pooled Two-stage Non-linear mixed effects
23
Nonlinear mixed effects modelling
Fixed effects, population typical values (e.g.: CLpop, VDpop, Kapop) Random effects Inter and intraindividual variability Residual variability
24
NONMEM NON linear Mixed Effects Modelling Structural model e.g.
Error model Describes difference between observation and model prediction Mixed effects: Fixed effects (structure) and Random effects (error)
25
All models are wrong, some are useful
26
Using models Simulations Minimising utility functions
27
Outline Principles of PKPD in microbiology and infectious diseases
Introduction to nonlinear mixed effects modelling Scaling pharmacokinetics between adults and children
28
“Children are not small adults”
Kearns 2003 VS. “Children are small adults” Tod 2008 and adults?
29
“Children are small adults”
CL often better correlated with BSA than wt (Cawford 1950) BMR correlated with wt0.75 (Kleiber 1947)
30
“Children are small adults”
31
“Children are small adults”
32
Scaling in PK: Tod et al 2008 MF = maturation function
OF = organ function
33
Scaling in PK: Maturation
Anderson 2010, Midazolam maturation
34
Outline Principles of PKPD in microbiology and infectious diseases
Introduction to nonlinear mixed effects modelling Scaling pharmacokinetics between adults and children
36
Scaling in PK – Organ Function
Ceriotti et al 2008 Note: Age in years
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.